🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Insurance denied me AGAIN - I am so frustrated

Insurance denied me AGAIN - I am so frustrated

InsuranceTom Sat, Mar 14, 2026 at 11:39 PM 22 replies 902 viewsPage 1 of 5
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Mar 14, 2026 at 11:39 PM#1

Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the talking.

The bit I cannot resolve on my own is what actually works on a prior-authorisation denial, as opposed to the list of things that sound like they should work.

Happy to be told the question itself is wrong.

25 20lisa_labSD, adam_van, Dr.SurgeonPGH and 22 others
Reply Quote Save Share Report
Dr.SportsMedIN
Senior Member
1,456
6,789
Feb 2024
Indianapolis, IN
Mar 15, 2026 at 1:54 AM#2
InsuranceTom said:
Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…

Financial impact of cost and coverage weight loss beyond medication cost:

  • Groceries: SAVED $266/month (eating less)
  • Restaurants: SAVED $176/month (fewer meals out)
  • Alcohol: SAVED $126/month (stopped drinking)
  • Life insurance: Premium REDUCED by $36/month (lower BMI)
  • Copays: SAVED $66/month (fewer BP/cholesterol meds)

Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.

Last edited: Mar 15, 2026 at 6:54 AM
24 19lisa_labSD, adam_van, Dr.SurgeonPGH and 21 others
Reply Quote Save Share Report
AttorneyGrant
Member
567
2,890
Apr 2024
Washington, DC
Mar 15, 2026 at 4:09 AM#3
Dr.SportsMedIN said:
Financial impact of cost and coverage weight loss beyond medication cost: Groceries: SAVED $266/month (eating less) Restaurants: SAVED $176/month…
Dr.SportsMedIN said:
...regarding the discontinuation data for cost and coverage...

I want to reframe the discontinuation narrative. We don't say "insulin fails because blood sugar rises when you stop it." We don't say "antihypertensives fail because BP goes up without them."

Why do we apply different logic to anti-obesity medications? The answer is stigma. We still, unconsciously, believe obesity is about willpower rather than biology. The discontinuation data actually PROVES it's a chronic biological condition requiring ongoing treatment.

This reframing isn't semantic — it has implications for insurance coverage, treatment duration, and patient expectations.

Last edited: Mar 15, 2026 at 5:09 AM
23 18JenMemphis, pat_auckland, Dr.GastroMayo and 20 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Mar 15, 2026 at 6:24 AM#4
InsuranceTom said:
Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…

Second this. I had assumed I was the exception until I read this.

22 17Dr.PathRoch, mona_PHX, andrew_nyc and 19 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Mar 15, 2026 at 7:52 PM#5

Clinical perspective, offered as context rather than as advice.

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:

  1. Prior authorization appeal with peer-to-peer review
  2. Manufacturer copay card (for commercial insurance)
  3. Patient assistance programs (Novo Nordisk, Eli Lilly)
  4. Compounded medication from a 503B pharmacy ($114/month)
  5. Canadian pharmacy (requires prescription, ~40-60% savings)

Don't let cost prevent access to effective treatment. There are options at every price point.

21 16Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 18 others
Reply Quote Save Share Report
1235

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register